Accelerated Hyperfractionated Radiotherapy and Concurrent Protracted Venous Infusion Chemotherapy in Locally Advanced Head and Neck Cancer-Reference-Cited by-同舟云学术

Accelerated Hyperfractionated Radiotherapy and Concurrent Protracted Venous Infusion Chemotherapy in Locally Advanced Head and Neck Cancer

Published:2002-10 Issue:5 Volume:25 Page:431-437
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:American Journal of Clinical Oncology

Author:

Arcangeli Giorgio,Saracino Biancamaria,Danesi Donatella Tirindelli,de Campora Enrico,Giovinazzo Giuseppe,Cognetti Francesco,Carlini Paolo,Arcangeli Stefano,Mecozzi Antonella

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference37 articles.

1. Combined radiation and drugs: The effect of intra-arterial chemotherapy followed by radiotherapy in head and neck cancer

2. Adjuvant chemotherapy for advanced head and neck squamous carcinoma

3. Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized Phase III study

4. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organ preservation protocols in developing countries;Current Opinion in Otolaryngology & Head & Neck Surgery;2010-04

2. Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF);Radiotherapy and Oncology;2007-10

3. Cisplatin and Continuous Infusion Fluorouracil (CF) for Head and Neck Cancers;Hospital Pharmacy;2005-09

4. Phase II Trial of Hyperfractionated Accelerated Split-Course Radiochemotherapy with 5-FU and Cis-DDP in Advanced Head and Neck Cancer;Strahlentherapie und Onkologie;2004-12

5. Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices;Supportive Care in Cancer;2004-09-15